Neff BJ - Search Results

1

Clinical and laboratory studies of KMcC strain live attenuated varicella virus.

Neff BJ, Weibel RE, Villarejos VM, Buynak EB, McLean AA, Morton DH, Wolanski BS, Hilleman MR. Neff BJ, et al. Proc Soc Exp Biol Med. 1981 Mar;166(3):339-47. doi: 10.3181/00379727-166-41071. Proc Soc Exp Biol Med. 1981. PMID: 6259644 Clinical Trial. No abstract available.

2

Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169.

Neff BJ, Weibel RE, Buynak EB, McLean AA, Hilleman MR. Neff BJ, et al. Proc Soc Exp Biol Med. 1979 Jan;160(1):32-7. doi: 10.3181/00379727-160-40382. Proc Soc Exp Biol Med. 1979. PMID: 217022 No abstract available.

3

Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB, et al. Weibel RE, et al. Among authors: neff bj. N Engl J Med. 1984 May 31;310(22):1409-15. doi: 10.1056/NEJM198405313102201. N Engl J Med. 1984. PMID: 6325909 Clinical Trial.

4

Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment.

Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, Morton D, McLean AA, Scolnick EM. Weibel RE, et al. Among authors: neff bj. JAMA. 1985 Nov 1;254(17):2435-9. JAMA. 1985. PMID: 2995697

5

Live attenuated varicella vaccine: the KMcC strain in healthy children.

Arbeter AM, Starr SE, Weibel RE, Neff BJ, Plotkin SA. Arbeter AM, et al. Among authors: neff bj. Pediatrics. 1983 Mar;71(3):307-12. Pediatrics. 1983. PMID: 6298698

6

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.

Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA. Kuter BJ, et al. Among authors: neff bj. Vaccine. 1991 Sep;9(9):643-7. doi: 10.1016/0264-410x(91)90189-d. Vaccine. 1991. PMID: 1659052 Clinical Trial.

7

Restriction endonuclease analysis of the DNA from varicella-zoster virus: stability of the DNA after passage in vitro.

Zweerink HJ, Morton DH, Stanton LW, Neff BJ. Zweerink HJ, et al. Among authors: neff bj. J Gen Virol. 1981 Jul;55(Pt 1):207-11. doi: 10.1099/0022-1317-55-1-207. J Gen Virol. 1981. PMID: 6271904

8

Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys.

Asano Y, Albrecht P, Behr DE, Neff BJ, Vickers JH, Rastogi SC. Asano Y, et al. Among authors: neff bj. J Med Virol. 1984;14(4):305-12. doi: 10.1002/jmv.1890140403. J Med Virol. 1984. PMID: 6096500

9

Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.

Zweerink HJ, Neff BJ. Zweerink HJ, et al. Among authors: neff bj. Infect Immun. 1981 Jan;31(1):436-44. doi: 10.1128/iai.31.1.436-444.1981. Infect Immun. 1981. PMID: 6260665 Free PMC article.

10

Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.

Keller PM, Lonergan K, Neff BJ, Morton DA, Ellis RW. Keller PM, et al. Among authors: neff bj. J Virol Methods. 1986 Sep;14(2):177-88. doi: 10.1016/0166-0934(86)90048-0. J Virol Methods. 1986. PMID: 3021804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters